BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 13, 2020
View Archived Issues
ADAM9 expression correlates with poor survival in TNBC
Read More
Discovery of novel BET protein degraders as oncolytic drug candidates
Read More
Crosstalk between sex, stress hormones affects immunity
Read More
Astrocytes, endocannabinoids, metabolism cooperate to affect behavior
Read More
Liver-specific silencing of MCJ reduces steatosis, inflammation and fibrosis in NASH mouse models
Read More
Roche synthesizes new imidazopyrazine antibacterials
Read More
Humanwell Healthcare, Hubei Bio-Pharmaceutical patent PDE4 inhibitors
Read More
Phase II study of CS-02 meets primary endpoint
Read More
New SMARCA2 inhibitors identified at Bayer
Read More
Imperial Innovations Group presents N-myristoyltransferase inhibitors
Read More
Svenox Pharmaceuticals presents new antitubercular compounds
Read More
Aptahem and University Health Network collaborate to develop Apta-1 for treatment of COVID-19
Read More
First-in-human study of INV-1120
Read More
Aligos Therapeutics presents preclinical data on ALG-031048
Read More
NBE-Therapeutics initiates phase I/II study of NBE-002
Read More
Enrollment ongoing in phase I study of KBL-693
Read More
Celldex Therapeutics starts enrollment in phase I study of CDX-527
Read More
BRAF inhibitor ABM-1310 displays potent efficacy in xenograft cancer models
Read More
Oragenics advances TerraCoV2, ends development of AG-013 for oral mucositis
Read More
Alzumab approved in India for emergency use to treat CRS in patients with COVID-19-related ARDS
Read More
Australia's TGA grants provisional approval to remdesivir
Read More
Beta Pharma begins phase I/II study of BPI-1178 in advanced solid tumors and breast cancer
Read More
Mutation drives checkpoint resistance in gastric cancer
Read More
